Achimastos, A. Alexandrides, T. Alexopoulos, D. Athyros, V. Bargiota, A. Bilianou, E. Chrysochoou, C. Drogari, E. Elisaf, M. Ganotakis, E. Goudevenos, I. Ioannidis, I. Kolovou, G. Kotsis, V. Lekakis, I. Liberopoulos, E. Melidonis, A. Nikolaou, V. Ntaios, G. Papanas, N. Pappas, S. Pitsavos, C. Rallidis, L. Richter, D. Skoumas, I. Tentolouris, N. Tousoulis, D. Tselepis, A. Tsioufis, K. Tziakas, D. Tziomalos, K. Vardas, P. Vlachopoulo, C. Vlahakos, D., Expert consensus on the rational clinical use of proprotein convertase subtilisin/kexin type 9 (PCSK9) inhibitors, Vitamins and Hormones, (15), 8-14, 2016, Hellenic Endocrine Society,